Armephaco JSC

Armephaco JSC OCF/Debt

The Operating Cash Flow to Debt Ratio of Armephaco JSC (AMP.VN) as of Oct 18, 2026 is -9.10 %. In the previous year, Operating Cash Flow to Debt Ratio was 5.26 % — a change of -272.95% (lower).

OCF/Debt

-9.10 %

YoY

-272.95%

Last updated:

Operating Cash Flow to Debt Ratio of Armephaco JSC is 2024 -9.10 % . Operating Cash Flow to Debt Ratio of Armephaco JSC was 2023 5.26 % . It decreases by -272.95% lower compared to the previous year.

The Armephaco JSC OCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OCF/Debt
Date
OCF/Debt
Jan 1, 2017
0.03 VND
Jan 1, 2018
-2.75 VND
Jan 1, 2019
0.81 VND
Jan 1, 2020
-2.58 VND
Jan 1, 2021
16.68 VND
Jan 1, 2022
2.87 VND
Jan 1, 2023
5.26 VND
Jan 1, 2024
-9.10 VND
The Armephaco JSC OCF/Debt history
YEAROCF/DebtYoY
-9.10 %-272.95%
5.26 %+83.05%
2.87 %-82.76%
16.68 %-746.62%
-2.58 %-417.18%
0.81 %-129.61%
-2.75 %-8,995.41%
0.03 %-100.09%
-35.50 %-94,465.68%
0.04 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

Operating Cash Flow to Debt Ratio of Armephaco JSC is -9.10 % in 2024.

Operating Cash Flow to Debt Ratio of Armephaco JSC changed from 5.26 % to -9.10 %, representing a -272.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow to Debt Ratio Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

OCF/Debt measures what percentage of total debt can be covered by annual operating cash flow. Higher ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Cash Flow to Debt Ratio's Armephaco JSC with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Armephaco JSC

All Key Metrics — Armephaco JSC